Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

electroCore, Inc. (ECOR)

Compare
5.98
-0.23
(-3.70%)
At close: 4:00:02 PM EDT
5.98
0.00
(0.00%)
After hours: 4:05:05 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Daniel S. Goldberger CEO & Director 1.13M -- 1959
Dr. Thomas J. Errico M.D. Founder & Independent Director 67.5k -- 1953
Mr. Joshua S. Lev Chief Financial Officer 605.1k -- 1985
Mr. Brian M. Posner CPA, MBA. Consultant 521.05k -- 1962
Mr. Donald Melnikoff Senior Vice President of Engineering, Regulatory & Compliance -- -- --
Mr. Mitch Deshon Vice President of Global Sales & Business Development -- -- --
Mr. Michael Mansfield Vice President of Marketing -- -- --
Ms. Carrie Kochek Senior Director of Human Resources -- -- --
Dr. Peter S. Staats M.B.A., M.D. Chief Medical Officer 238.41k -- 1964
Mr. Manuel A. Marques Senior Vice President of Operations -- -- 1973

electroCore, Inc.

200 Forge Way
Suite 205
Rockaway, NJ 07866
United States
973 290 0097 https://www.electrocore.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
73

Description

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Corporate Governance

electroCore, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 6, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

electroCore, Inc. Earnings Date

Recent Events

April 3, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 12, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 28, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 31, 2025 at 12:00 AM UTC

S-3/A: Offering Registrations

January 24, 2025 at 12:00 AM UTC

S-3: Offering Registrations

January 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 29, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 15, 2024 at 12:00 AM UTC

D: Additional Forms

November 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers